Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares traded up 16.7% during mid-day trading on Monday . The company traded as high as GBX 20 ($0.25) and last traded at GBX 17.50 ($0.22). 27,811 shares traded hands during trading, a decline of 64% from the average session volume of 77,314 shares. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Stock Up 16.7 %
The company has a fifty day moving average price of GBX 21.96 and a 200 day moving average price of GBX 41.40. The company has a market cap of £12.05 million, a PE ratio of -218.75 and a beta of -0.26. The company has a debt-to-equity ratio of 194.82, a current ratio of 1.92 and a quick ratio of 6.97.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Recommended Stories
- Five stocks we like better than Celadon Pharmaceuticals
- What Are Some of the Best Large-Cap Stocks to Buy?
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Investing in Construction Stocks
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- 3 REITs to Buy and Hold for the Long Term
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
